US$ 28.69
tirzepatide i danmark Price pressure on weight-loss drugs slows Eli Lilly's growth engine in the first quarter Compounded Injectable Tirzepatide
Description
Those on the drug were less likely to die of cardiovascular causes or have their heart failure condition worsen compared with people taking the placebo

Sergey Terushkin, MD, FACS is a fellowship-trained bariatric surgeon with experience in bariatric surgery, obesity medicine, medical weight loss, and long-term weight management

Refunded in full if it's not right for you

The trial followed 731 adults with heart failure with preserved ejection fraction (HFpEF) and obesity who received either tirzepatide or a placebo over the course of a year